The Feasibility Of Expectant Management Versus Induction At 38 Weeks Among Individuals With Gestational Diabetes Mellitus: A Randomized Controlled Pilot Trial (EAGER Pilot Trial) (EAGER Pilot)
The Feasibility Of Expectant Management Versus Induction At 38 Weeks Among Individuals With Gestational Diabetes Mellitus: A Randomized Controlled Pilot Trial
Sponsor: Ottawa Hospital Research Institute
Listed as NCT06641141, this NA trial focuses on Gestational Diabetes Mellitus (GDM) and remains actively recruiting participants. Sponsored by Ottawa Hospital Research Institute, it has been updated 5 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Dec 2025 — Present [monthly]
Recruiting NA
-
May 2025 — Dec 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2025 — May 2025 [monthly]
Not Yet Recruiting NA
-
Dec 2024 — Jan 2025 [monthly]
Not Yet Recruiting NA
-
Nov 2024 — Dec 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ottawa Hospital Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .